Business · 21/01/2016Updated: 10/17/2026 · 1 min read
FDA Amends Animal Drug Regulations to Remove Conditional Approval of Masitinib
Summary
The US Food and Drug Administration (FDA) is updating its regulations to reflect that the conditional approval of masitinib mesylate tablets, a new animal drug for a minor use, is no longer in effect.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →